The Role of nab-Paclitaxel Plus Gemcitabine Therapy for Recurrent Pancreatic Cancer Refractory to Gemcitabine and S-1

被引：0
|
作者：
Kagawa, S. [1 ]
Yoshitomi, H. [1 ]
Shimizu, H. [1 ]
Ohtsuka, M. [1 ]
Kato, A. [1 ]
Furukawa, K. [1 ]
Takayashiki, T. [1 ]
Takano, S. [1 ]
Kuboki, S. [1 ]
Suzuki, D. [1 ]
Sakai, N. [1 ]
Miyazaki, M. [1 ]
机构：
[1] Chiba Univ, Grad Sch Med, Dept Gen Surg, Chiba, Japan
来源：
PANCREAS | 2015年 / 44卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1385 / 1385
页数：1
相关论文
共 50 条
  • [1] A retrospective analysis of S-1 in patients with Gemcitabine plus nab-Paclitaxel refractory pancreatic cancer
    Tsumura, Hidetaka
    Sakai, Hideki
    Tokuyama, Nagahiro
    Kushida, Saeko
    Sakai, Aya
    Mimura, Takuya
    Sakamoto, Takeshi
    Yamamoto, Yoshinobu
    Miki, Ikuya
    Tsuda, Masahiro
    ANNALS OF ONCOLOGY, 2017, 28
  • [2] Feasibility of Combination Therapy with Nab-paclitaxel Plus Gemcitabine in Patients with Recurrent Pancreatic Cancer
    Kawaida, Hiromichi
    Kono, Hiroshi
    Amemiya, Hidetake
    Saitou, Ryou
    Yamamoto, Atsushi
    Hosomura, Naohiro
    Watanabe, Mitsuaki
    Kimura, Ayako
    Furuya, Shinji
    Shimizu, Hiroki
    Akaike, Hidenori
    Kawaguchi, Yoshihiko
    Sudo, Makoto
    Itakura, Jun
    Hayakawa, Hiroshi
    Shindo, Hiroko
    Takahashi, Ei
    Takano, Shinichi
    Fukasawa, Mitsuharu
    Ichikawa, Shintaro
    Fujii, Hideki
    Ichikawa, Daisuke
    ANTICANCER RESEARCH, 2018, 38 (11) : 6537 - 6542
  • [3] A Retrospective Study of Gemcitabine Plus Nab-Paclitaxel for Advanced Pancreatic Cancer Refractory to Gemcitabine Monotherapy
    Nishioka, Mariko
    Okano, Naohiro
    Wakabayashi, Masashi
    Ikeno, Takashi
    Hayashi, Masato
    Mizutani, Tomonori
    Nagashima, Fumio
    Furuse, Junji
    ANTICANCER RESEARCH, 2024, 44 (03) : 1233 - 1239
  • [4] Chemotherapy in Pancreatic Cancer: Comparative Study of Gemcitabine, S-1, and FOLFIRINOX, Nab-Paclitaxel plus Gem
    Miyata, H.
    Yamago, H.
    Ueki, H.
    Nagamatsu, K.
    Iwasaki, R.
    PANCREAS, 2019, 48 (10) : 1492 - 1492
  • [5] Nab-paclitaxel plus S-1 versus nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer: a multicenter, randomized, phase II study
    Jin, Min
    Liu, Hong-Li
    Xue, Jun
    Ma, Hong
    Liu, Jun-Li
    Lin, Zhen-Yu
    Wang, Jing
    Bao, Le-Qun
    Luo, Zhi-Guo
    Yu, Xiong-Jie
    Li, Shuang
    Hu, Jian-Li
    Zhang, Tao
    ONCOLOGIST, 2024,
  • [6] Efficacy and toxicity comparison of nab-paclitaxel plus S-1 and nab-paclitaxel plus gemcitabine as first-line chemotherapy for metastatic pancreatic cancer
    Guo Xi
    Xu Yaolin
    Ji Yuan
    Fan Yue
    Wang Dansong
    Jin Dayong
    Zhuang Rongyuan
    Wu Lili
    Lou Wenhui
    Zhou Yuhong
    Department of Medical Oncology
    Department of General Surgery
    Department of Pathology
    Department of Traditional Chinese Medicine
    Department of Radiotherapy
    胰腺病学杂志(英文), 2020, 03 (01) : 35 - 41
  • [7] Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
    Von Hoff, Daniel D.
    Ervin, Thomas
    Arena, Francis P.
    Chiorean, E. Gabriela
    Infante, Jeffrey
    Moore, Malcolm
    Seay, Thomas
    Tjulandin, Sergei A.
    Ma, Wen Wee
    Saleh, Mansoor N.
    Harris, Marion
    Reni, Michele
    Dowden, Scot
    Laheru, Daniel
    Bahary, Nathan
    Ramanathan, Ramesh K.
    Tabernero, Josep
    Hidalgo, Manuel
    Goldstein, David
    Van Cutsem, Eric
    Wei, Xinyu
    Iglesias, Jose
    Renschler, Markus F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (18): : 1691 - 1703
  • [8] Comparison of adjuvant nab-paclitaxel plus gemcitabine, S-1 and gemcitabine chemotherapy for resectable pancreatic cancer: a real-world study
    Li, Haorui
    Guo, Yu
    Sun, Xugang
    Lu, Yang
    Chang, Shaofei
    Wang, Xiuchao
    Gao, Song
    Gao, Chuntao
    Zhao, Tiansuo
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [9] Maintenance treatment with gemcitabine after gemcitabine plus Nab-paclitaxel in advanced pancreatic cancer
    Kodama, Tomoko
    Nakazawa, Junichi
    Kawahira, Masahiro
    Ymasuji, Akihiro
    Iwashita, Yuji
    Hori, Takeshi
    Kawahira, Machiko
    Arima, Shiho
    Tubouchi, Hirohito
    Ido, Akio
    ANNALS OF ONCOLOGY, 2022, 33 : S484 - S484
  • [10] Clinical Outcomes of S-1 Monotherapy and Modified FOLFIRINOX Therapy after Gemcitabine plus Nab-paclitaxel Therapy in Unresectable Pancreatic Cancer
    Hino, Kaori
    Nishina, Tomohiro
    Numata, Yuuki
    Asagi, Akinori
    Inoue, Tomonori
    Yoshimatsu, Megumi
    Sakaguchi, Chihiro
    Nakasya, Akio
    Nishide, Norifumi
    Kajiwara, Takeshi
    Terao, Takashi
    Nadano, Seijin
    Marui, Kaori
    Okujima, Yusuke
    Kokubu, Masahito
    Imamura, Yoshiki
    Kanemitsu, Kozue
    Koizumi, Mitsuhito
    Kumagi, Teru
    Hiasa, Yoichi
    Hyodo, Ichinosuke
    INTERNAL MEDICINE, 2022, 61 (15) : 2255 - 2261
12345